GKOS
USDGlaukos Corporation Common Stock
실시간 가격
가격 차트
핵심 지표
시장 지표
시가
$85.860
고가
$88.290
저가
$85.235
거래량
0.50M
기업 기본 정보
시가총액
4.9B
산업
의료 기기
국가
United States
거래 통계
평균 거래량
1.05M
거래소
NYQ
통화
USD
52주 범위
관련 뉴스
Glaukos Announces Participation in Upcoming Investor Conferences
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its
JP Morgan Maintains Overweight on Glaukos, Raises Price Target to $120
JP Morgan analyst Allen Gong maintains Glaukos with a Overweight and raises the price target from $110 to $120.
Citigroup Maintains Buy on Glaukos, Raises Price Target to $113
Citigroup analyst Joanne Wuensch maintains Glaukos with a Buy and raises the price target from $110 to $113.
Wells Fargo Maintains Overweight on Glaukos, Raises Price Target to $122
Wells Fargo analyst Larry Biegelsen maintains Glaukos with a Overweight and raises the price target from $120 to $122.
Needham Maintains Buy on Glaukos, Raises Price Target to $117
Needham analyst David Saxon maintains Glaukos with a Buy and raises the price target from $115 to $117.
BTIG Maintains Buy on Glaukos, Raises Price Target to $116
BTIG analyst Ryan Zimmerman maintains Glaukos with a Buy and raises the price target from $104 to $116.
Glaukos Announces Third Quarter 2025 Financial Results
Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced financial
관련 주식
최신 정보 받기
가격 알림 설정, AI 분석 업데이트 및 실시간 시장 뉴스 받기